Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)
HIV Infections
About this trial
This is an interventional treatment trial for HIV Infections focused on measuring Immune Tolerance, AIDS-Related Complex, Zidovudine
Eligibility Criteria
Inclusion Criteria Patient must have AIDS related complex (ARC) as defined by Walter Reed stages, be ambulatory, and be able to give informed consent. Exclusion Criteria Co-existing Condition: Patients with unstable disease characterized by the following are excluded: Hospitalization within the past 14 days. Major opportunistic infection, current or past. An active infection of onset during the past 30 days, as evidenced by symptoms, signs, or laboratory abnormalities such as: Temperature = or > 100.5 degrees F. Night sweats. Weight loss = or > 10 percent of body weight. Diarrhea (3 or more bowel movements/day). Persistent cough, shortness of breath, or dyspnea on exercise. Abnormal chest x-ray suggesting pneumonia or increased arterial-alveolar (A-a) gradient. Altered mental status, seizures, or focal neurologic signs. Abnormal computerized tomography (CT) scan or magnetic resonance imaging (MRI) suggestive of toxoplasmosis, peripheral mononuclear leukocytes, lymphoma, or other focal abnormality of the central nervous system (CNS). Abnormal cerebrospinal fluid (CSF) suggestive of cryptococcal, mycobacterial, or other meningitis. (The decision to perform invasive tests, such as lumbar puncture, specialized microbiological tests such as bone marrow culture for Mycobacteria or Histoplasma capsulatum, or specialized radiological tests such as CT scan or MRI should be based on clinical assessment of the patient.) Kaposi's sarcoma. Lymphoma; malignancy requiring chemotherapy. Dementia. Requiring hemodialysis or renal insufficiency or failure. Leukopenia. Thrombocytopenia. Patients with the following are excluded: Unstable disease. Kaposi's sarcoma. Lymphoma; malignancy requiring chemotherapy. Dementia. Major opportunistic infection, current or past. Anemia (hemoglobin less than 9.5 g/dl). Prior Medication: Excluded within 1 month of study entry: Ribavirin or zidovudine (AZT) or other antivirals. Immunomodulating agents.
Sites / Locations
- Wadsworth Veterans Administration Med Ctr
- San Francisco Veterans Administration Med Ctr
- Walter Reed Army Med Ctr
- Veterans Administration Med Ctr
- Dr Gordon Dickinson
- Dr Gigi Diamond / New York Veterans Administration
- Veterans Affairs Med Ctr / Admin Only / Not For Patient Care
- Houston Veterans Administration Med Ctr